ImportRefusal LogoImportRefusal

kama industries ltd

⚠️ High Risk

FEI: 3010103480 • Accra • GHANA

FEI

FEI Number

3010103480

📍

Location

Accra

🇬🇭

Country

GHANA
🏢

Address

NORTH, PO Box 5437, Accra, , Ghana

High Risk

FDA Import Risk Assessment

60.2
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

16
Total Refusals
7
Unique Violations
8/12/2025
Latest Refusal
3/23/2005
Earliest Refusal

Score Breakdown

Violation Severity
68.5×40%
Refusal Volume
45.6×30%
Recency
91.7×20%
Frequency
7.8×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7514×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1187×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

167×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

4722×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

32802×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

3361×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

37411×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(o) in that it is being imported or offered for import into the United States, and the importer, owner, or consignee of such article did not, at the time of offering the article for import, submit to the Secretary a statement that identifies the registration under section 510(i) of the Act of each establishment that with respect to such article is required under such section to register with the Secretary.

Refusal History

DateProductViolationsDivision
8/12/2025
54AEY99VITAMIN, N.E.C.
75UNAPPROVED
Division of Northeast Imports (DNEI)
6/11/2024
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Northeast Imports (DNEI)
4/29/2022
61XBL14CYPROHEPTADINE HCL (ANTI-HISTAMINIC)
75UNAPPROVED
Division of Northeast Imports (DNEI)
8/19/2021
66VDL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Northeast Imports (DNEI)
3/10/2021
61XAL14CYPROHEPTADINE HCL (ANTI-HISTAMINIC)
75UNAPPROVED
Division of Northeast Imports (DNEI)
1/19/2021
61XAL14CYPROHEPTADINE HCL (ANTI-HISTAMINIC)
75UNAPPROVED
Division of Northeast Imports (DNEI)
4/6/2020
61XDK14CYPROHEPTADINE HCL (ANTI-HISTAMINIC)
75UNAPPROVED
Division of Northeast Imports (DNEI)
11/1/2018
61XBN14CYPROHEPTADINE HCL (ANTI-HISTAMINIC)
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
336INCONSPICU
75UNAPPROVED
Division of Northeast Imports (DNEI)
9/8/2017
61XBL14CYPROHEPTADINE HCL (ANTI-HISTAMINIC)
118NOT LISTED
16DIRECTIONS
75UNAPPROVED
Division of Northeast Imports (DNEI)
8/27/2014
61XCL14CYPROHEPTADINE HCL (ANTI-HISTAMINIC)
16DIRECTIONS
75UNAPPROVED
Division of Northeast Imports (DNEI)
6/6/2014
61XBN14CYPROHEPTADINE HCL (ANTI-HISTAMINIC)
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
472NO ENGLISH
75UNAPPROVED
Division of Northeast Imports (DNEI)
1/13/2014
61XMK14CYPROHEPTADINE HCL (ANTI-HISTAMINIC)
118NOT LISTED
16DIRECTIONS
New York District Office (NYK-DO)
5/28/2013
61XMK14CYPROHEPTADINE HCL (ANTI-HISTAMINIC)
16DIRECTIONS
Division of Northeast Imports (DNEI)
2/20/2013
61XDK14CYPROHEPTADINE HCL (ANTI-HISTAMINIC)
118NOT LISTED
16DIRECTIONS
3741FRNMFGREG
472NO ENGLISH
75UNAPPROVED
Division of Northeast Imports (DNEI)
2/16/2010
61XDL14CYPROHEPTADINE HCL (ANTI-HISTAMINIC)
118NOT LISTED
75UNAPPROVED
New England District Office (NWE-DO)
3/23/2005
60LDL99ANALGESIC, N.E.C.
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)

Frequently Asked Questions

What is kama industries ltd's FDA import refusal history?

kama industries ltd (FEI: 3010103480) has 16 FDA import refusal record(s) in our database, spanning from 3/23/2005 to 8/12/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. kama industries ltd's FEI number is 3010103480.

What types of violations has kama industries ltd received?

kama industries ltd has been cited for 7 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about kama industries ltd come from?

All FDA import refusal data for kama industries ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.